September 25, 2021 Chula Radio plus has released a new SoundCloud with the...
https://soundcloud.com/curadio1015/ep30-emerging-infectious-diseases-search-for-new-vaccines Emerging infectious diseases are defined as diseases in which incidence in humans has increased in the past...
View ArticleBaiya’s co-founders have been interviewed by the press association Sky news...
“COVID-19 is not going to be the last one, right? You’re going to have so many emerging diseases and if we can develop the vaccine ourselves, then we don’t have to rely on vaccines from other...
View ArticleBaiya’s CEO was interviewed on CNBC’s “Managing Asia” about “A Thai start-up...
The start-up, founded by Dr. Suthira Taychakhoonavudh and Dr. Waranyoo Phoolcharoen in 2018, has been working on a vaccine using the leaves of an Australian tobacco plant. Suthira, a 37-year-old...
View ArticleBaiyaPhytopharm Announces Preliminary Results of the Phase 1 Clinical Trial...
Baiya SARS-CoV-2 Vax 2, an adjuvant-containing protein vaccine based on antigens produced in plants by BaiyaPharmingTM, is undergoing clinical trials after showing favorable induced response to...
View ArticleChula Radio plus has released a new SoundCloud with the topic of “Emerging...
Emerging infectious diseases are defined as diseases in which incidence in humans has increased in the past two decades, or threatens to increase in the near future. They can be either newly...
View ArticleBaiya’s co-founders have been interviewed by the press association Sky news...
“COVID-19 is not going to be the last one, right? You’re going to have so many emerging diseases and if we can develop the vaccine ourselves, then we don’t have to rely on vaccines from other...
View ArticleBaiya’s CEO was interviewed on CNBC’s “Managing Asia” about “A Thai start-up...
The start-up, founded by Dr. Suthira Taychakhoonavudh and Dr. Waranyoo Phoolcharoen in 2018, has been working on a vaccine using the leaves of an Australian tobacco plant. Suthira, a 37-year-old...
View ArticleBaiyaPhytopharm Announces Preliminary Results of the Phase 1 Clinical Trial...
Baiya SARS-CoV-2 Vax 2, an adjuvant-containing protein vaccine based on antigens produced in plants by BaiyaPharmingTM, is undergoing clinical trials after showing favorable induced response to...
View Article